10th-Feb-2012 16:12Source: BSE

Aurobindo Pharm- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

K Nithyananda Reddy has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE

10th-Feb-2012 15:17Source: BSE

Aurobindo Pharm- Q3 results rescheduled on Feb 13, 2012

With reference to the earlier announcement dated January 30, 2012 regarding Q3 results on Feb 10, 2012, Aurobindo Pharma Ltd has now informed BSE that the Board Meeting proposed on February 10, 2012 t...

9th-Feb-2012 11:41Source: NSE

Aurobindo Pharma Limited

K. Nithyananda Reddy has submitted to the Exchange a copy of Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

1st-Feb-2012 08:19Source: NSE

Aurobindo Pharma Limited

M. Sumanth Kumar Reddy has submitted to the Exchange a copy of Disclosure u/r 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and regulation 13(4A) of SEBI (Prohibiti...

1st-Feb-2012 08:19Source: NSE

Aurobindo Pharma Limited

Kambam Spoorthi has submitted to the Exchange a copy of Disclosure u/r 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and regulation 13(4A) of SEBI (Prohibition of I...

31st-Jan-2012 16:44Source: BSE

Aurobindo Pharm- Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Aurobindo Pharma Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:

31st-Jan-2012 16:40Source: BSE

Aurobindo Pharm- Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Aurobindo Pharma Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:

31st-Jan-2012 16:13Source: BSE

Aurobindo Pharm- Disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Kambam Spoorthi has submitted the disclosure under Regulation 13(4), 13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:

31st-Jan-2012 16:13Source: BSE

Aurobindo Pharm- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Kambam Spoorthi has submitted the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE.

31st-Jan-2012 16:11Source: BSE

Aurobindo Pharm- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

M Sumanth Kumar Reddy has submitted the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE.